Kazi Uddin

Associate Researcher, Docent, PhDKnown as name: Julhash U. Kazi
More filtering options
  1. Article
  2. FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications

    Julhash U. Kazi & Lars Rönnstrand, 2019, In : Physiological Reviews. 99, 3, p. 1433-1466 34 p.

    Research output: Contribution to journalArticle

  3. De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia

    Hyrenius-Wittsten, A., Pilheden, M., Sturesson, H., Hansson, J., Walsh, M. P., Song, G., Kazi, J. U., Liu, J., Ramakrishan, R., Garcia-Ruiz, C., Nance, S., Gupta, P., Zhang, J., Rönnstrand, L., Hultquist, A., Downing, J. R., Lindkvist-Petersson, K., Paulsson, K., Järås, M., Gruber, T. A. & 2 others, Ma, J. & Anna K. Hagström-Andersson, 2018 Dec 1, In : Nature Communications. 9, 1, 1770.

    Research output: Contribution to journalArticle

  4. Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma

    Li, T., Deng, Y., Shi, Y., Tian, R., Chen, Y., Zou, L., Julhash U. Kazi, Lars Rönnstrand, Feng, B., Chan, S. O., Chan, W. Y., Jianmin Sun & Zhao, H., 2018 Nov, In : Oncogene. 37, 47, p. 6180-6194

    Research output: Contribution to journalArticle

  5. The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation

    Marhäll, A., Julhash U. Kazi & Lars Rönnstrand, 2017 Dec 1, In : Scientific Reports. 7, 1, 13734.

    Research output: Contribution to journalArticle

  6. Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia

    Sausan A. Moharram, Kinjal Shah, Khanum, F., Marhäll, A., Mohiuddin, G. & Julhash U. Kazi, 2017 Oct 1, In : Cancer Letters. 405, p. 73-78 6 p.

    Research output: Contribution to journalArticle

  7. KITD816V induces SRC-mediated tyrosine phosphorylation of MITF and altered transcription program in melanoma

    Bengt Phung, Julhash U. Kazi, Lundby, A., Bergsteinsdottir, K., Jianmin Sun, Goding, C. R., Jonsson, G., Olsen, J. V., Steingrímsson, E. & Lars Ronnstrand, 2017 Sep 1, In : Molecular Cancer Research. 15, 9, p. 1265-1274 10 p.

    Research output: Contribution to journalArticle

  8. The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)

    Mohiuddin, G., Sausan A. Moharram, Marhäll, A. & Julhash U. Kazi, 2017 Apr 28, In : Cancer Letters. 392, p. 9-16 8 p.

    Research output: Contribution to journalArticle

  9. ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling

    Julhash U Kazi, Rupar, K., Marhäll, A., Sausan A Moharram, Khanum, F., Kinjal Shah, Mohiuddin, G., Mysore Nagaraj, S. R., Jianmin Sun, Chougule, R. A. & Lars Rönnstrand, 2017, In : Oncotarget. 8, 7, p. 12194-12202

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 Next